Level Four Advisory Services’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-236,800
| Closed | -$2.13M | – | 752 |
|
|
2024
Q1 | $2.13M | Hold |
236,800
| – | – | 0.12% | 192 |
|
|
2023
Q4 | $2.13M | Sell |
236,800
-15,300
| -6% | -$138K | 0.12% | 188 |
|
|
2023
Q3 | $1.96M | Buy |
252,100
+2,700
| +1% | +$21K | 0.13% | 190 |
|
|
2023
Q2 | $2.41M | Sell |
249,400
-800
| -0.3% | -$7.74K | 0.15% | 158 |
|
|
2023
Q1 | $2.74M | Buy |
250,200
+239,000
| +2,134% | +$2.62M | 0.18% | 137 |
|
|
2022
Q4 | $48.4K | Hold |
11,200
| – | – | ﹤0.01% | 655 |
|
|
2022
Q3 | $84K | Buy |
11,200
+1,000
| +10% | +$7.5K | 0.01% | 525 |
|
|
2022
Q2 | $103K | Buy |
+10,200
| New | +$103K | 0.01% | 535 |
|
|
2022
Q1 | – | Sell |
-10,650
| Closed | -$244K | – | 645 |
|
|
2021
Q4 | $244K | Buy |
+10,650
| New | +$244K | 0.02% | 559 |
|